The germline variant CTLA4 rs231775 may have clinical impact on disease severity and treatment outcome in DLBCL, with an association of the CTLA4 minor allele A17 to favorable outcome after CAR-T cell infusion. The gene discussed is CTLA4; the disease is diffuse large B-cell lymphoma.